Home > Insider Trading > Filing (0001415889-19-000021)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604191	Azurrx Biopharma Inc.	AZRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1682557	Jr. Burke Edmund Ross	C/O Jdj Family Office Services Po Box 962049 Boston MA 02196		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-05-02	20,000	$2.50	2,421,010	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2018-12-27	42,922	$1.18	2,463,932	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2018-12-27	23,200	$1.13	2,487,132	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2018-12-28	29,575	$1.18	2,516,707	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2018-12-31	23,848	$1.12	2,540,555	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Footnotes

Mr. Ross is the manager and holds sole voting and dispositive power over the shares of common stock and each of ADEC Private Equity Investment, LLC, EBR Ventures, LLC, and CEDA Investments, LLC disclaims beneficial ownership of such securities underlying the warrants, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that any of ADEC Private Equity Investment, LLC, EBR Ventures, LLC, or CEDA Investments, LLC is the beneficial owner of such securities for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Mr. Ross disclaims beneficial ownership of the securities described in this footnote except to the extent of his pecuniary interest.
Of the aggregate number of shares purchased on May 2, 2018, CEDA Investments, LLC purchased all 20,000 shares.
Of the aggregate number of shares purchased on December 27, 2018, EBR Ventures, LLC purchased all 66,122 shares.
Of the aggregate number of shares purchased on December 28, 2018, EBR Ventures, LLC purchased all 29,575 shares.
Of the aggregate number of shares purchased on December 31, 2018, EBR Ventures, LLC purchased all 23,848 shares.